Drug Eluting Balloon
September 21-25, 2010
TCT 2010 – Transcatheter Cardiovascular Therapeutics
B. Braun Vascular Systems, booth number 2035
Washington Convenion Center, Washington D.C., USA
http://www.tctconference.com
In addition, different lectures about Sequent® Please with PACCOCATH® Technology will be held:
The Drug Eluting Stent Summit (Part 2): Next Generation DES, Bioabsorbable Stents and Drug-Eluting Balloons
German Consensus Group Recommendations for DEB Development
Date: Wednesday, September 22, 2010
Time: 2:22 p.m. to 2:37 p.m.
Presenter: Bruno Scheller
The PACCOCATH® (Cotavance And Sequent Please) Paclitaxel DEB Technology and Compressive Review of All Completed and Planned Clinical Trials
Date: Wednesday, September 22, 2010
Time: 2:37 p.m. to 2:52 p.m.
Presenter: Detlef G. Mathey
First Report Investigations I – PERFECT STENT TRIAL
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients Treated with Endothelial Progenitor Cell Capturing Stents for De Novo Coronary Artery Disease
Date: Thursday, September 23, 2010
Time: 12:30 to 12:40 p.m.
Place: Washington Convention Center, Main Arena, Ballrooms ABC, Level 3
Presenter: Jochen Wöhrle
Moderated Discussion: Juan F. Granada
Featured Clinical Research III – PEPCAD-CTO
A prospective Nonradomized Study of Paclitaxel-Eluting Balloons After Bare Metal Stent Placement in Successfully Recanalized Chronic Total Occlusions.
Date: Friday, September 24, 2010
Time: 7:15 p.m. to 7:25 p.m.
Place: Washington Convention Center, Room 143B
Presenter: Gerald S. Werner
Furthermore B. Braun and Medrad organized a breakfast symposium on September 23, 2010.
Time: Breakfast at 6:30 a.m./ Program: 7:00 a.m.-8:00 a.m.
Place: Washington Convention Center, Room 144A
The title is : “What Pre-Clinical and Clinical Results Have Taught Us About the PACCOCATH® Drug-Eluting Balloon Technology: Not all Drug-Eluting Balloons are Created Equal”
Introduction (Moderator: Robert Schwartz)
Standardization of Technology and Testing for Drug Eluting Balloons
Clinical Evidence of the PACCOCATH® Technology – Overview of Coronary Clinical Studies
Speaker: Detlef G. Mathey
Practical Application of the PACCOCATH® Technology – Tips & Tricks
Speaker: Bruno Scheller
PACCOCATH® Technology Development Update – Insights into Safety and Efficacy of Latest Generation Cotavance Drug Eluting Balloon
Speaker: Juan Granada
PACCOCATH® Technology in Peripheral Applications – Prior Experience and Future Directions
Speaker: William Gray
Discussion among the panel and audience!
May 25-28, 2010
EURO PCR – Paris 2010
Paris, France
www.europcr.com
B. Braun and Medrad PCR Satellite Symposium “What Preclinical and Clinical Results have Taught us about the PACCOCATH® Drug Eluting Balloon (DEB) Coating Technology: Not all Drug Eluting Balloons are Created Equal”
Chairman: Eric Eeckhout/Ulrich Speck
Introduction: Development of the DEB Concept
Ulrich Speck (Charité Berlin, Germany)
Biological Concepts and Lessons Learned from the PACCOCATH® Technology in Pre-Clinical Animal Models
Juan Granada (Orangeburg, USA)
Animal Data and Clinical Results of Different Drug Eluting Balloon Systems
Bruno Scheller (Homburg/Saar, Germany)
The PEPCAD Clinical Trial Program
Detlef Mathey (Hamburg, Germany)
Practical Application of the PACCOCATH® Technology – Tricks and Tips
Franz-Xaver Kleber (Potsdam, Germany)
Paccocath® for Treatment of Peripheral Artery Disease
Gunnar Tepe (Tuebingen, Germany)
Future Horizons for the PACCOCATH® Technology
Nicolas Diehm (Bern, Switzerland)
Conclusion and Q&A Session with Panellists
Eric Eeckhout (Lausanne, Switzerland)
The complete panel discussion is available as a webcast containing the original presentations and statements on cardio-sympoisum.org